🔎 Trials Near Me

Utama › Degenerasi Makula › Indiana

Kajian klinikal Degenerasi Makula di Indiana

7 kajian untuk Degenerasi Makula sedang mencari peserta di lokasi di Indiana.

Bandar di Indiana

Teks kajian rasmi (Bahasa Inggeris)

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

  • Associated Vitreoretinal and Uveitis Consultants, Carmel
  • Midwest Eye Institute, Carmel
Mengambil pesertaFasa 2/3
Umur 50 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07440225

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  • Midwest Eye Institute, Carmel
Mengambil pesertaFasa 2/3
Umur 60 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06635148

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

  • Retina Partners Midwest, P.C., Carmel
Mengambil pesertaFasa 2
Umur 55 ke atas · Semua jantina · Dikemas kini 10 Sep 2026 · NCT06659445

4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration

  • Retina Partners Midwest, Carmel
Mengambil pesertaFasa 1/2
Umur 50 ke atas · Semua jantina · Dikemas kini 21 Ogo 2026 · NCT05197270

Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

  • Retina Partners Midwest, P.C. /ID# 262172, Carmel
Mengambil pesertaFasa 1/2
Umur 50 ke atas · Semua jantina · Dikemas kini 13 Jul 2026 · NCT07160179

Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

  • Retina Partners Midwest, PC, Carmel
Mengambil pesertaFasa 3
Umur 50 ke atas · Semua jantina · Dikemas kini 16 Apr 2026 · NCT07064759

Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration

  • CBCC Global Research Site:004, Carmel
Mengambil pesertaFasa 1
Umur 50 ke atas · Semua jantina · Dikemas kini 7 Feb 2025 · NCT06132035

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.